A nurse is administering fludrocortisone (Florinef), a mineralocorticoid, to a client who has Addison’s disease. What are some of the expected pharmacologic effects of fludrocortisone in this condition?
A.
It promotes sodium reabsorption and potassium excretion in the kidney, increasing blood volume and blood pressure.
B.
It reduces inflammation, pain, fever, and allergic reactions by inhibiting the synthesis of prostaglandins and leukotrienes.
C.
It regulates the secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary gland, maintaining the feedback loop of cortisol production.
D.
It influences the carbohydrate, protein, and fat metabolism in various tissues, increasing blood glucose and suppressing immune response.
The correct answer and Explanation is :
The correct answer is:
A. It promotes sodium reabsorption and potassium excretion in the kidney, increasing blood volume and blood pressure.
Explanation:
Fludrocortisone, a mineralocorticoid, is primarily used in the treatment of Addison’s disease, a condition characterized by insufficient production of adrenal hormones, particularly cortisol and aldosterone. Addison’s disease often results in a deficiency of aldosterone, which plays a crucial role in regulating sodium and potassium levels and maintaining blood pressure.
Fludrocortisone’s primary pharmacologic effect is its ability to mimic aldosterone. It acts on the kidneys to promote sodium reabsorption and enhance potassium excretion. This action helps in increasing blood volume by retaining sodium and subsequently water, which raises blood pressure. This is critical in Addison’s disease because the lack of aldosterone leads to low blood sodium, high blood potassium, and decreased blood volume, contributing to hypotension and electrolyte imbalances.
To break it down further:
- Sodium Reabsorption: Fludrocortisone enhances the reabsorption of sodium from the renal tubules back into the bloodstream. This increase in sodium reabsorption leads to an increase in blood volume because sodium attracts water.
- Potassium Excretion: Simultaneously, fludrocortisone promotes the excretion of potassium into the urine. Elevated potassium levels are a concern in Addison’s disease due to the lack of aldosterone.
- Blood Pressure: By increasing blood volume through sodium and water retention, fludrocortisone helps to elevate blood pressure, which is often low in individuals with Addison’s disease.
In summary, fludrocortisone’s primary role in managing Addison’s disease is to replace the deficient aldosterone and correct the electrolyte imbalances and hypotension associated with the condition.